Fosmidomycin resistance in adenylate cyclase deficient (cya) mutants of Escherichia coli

Biosci Biotechnol Biochem. 2003 Sep;67(9):2030-3. doi: 10.1271/bbb.67.2030.

Abstract

Adenylate cyclase deficient (cya) mutants of E. coli K-12 were found to be resistant to fosmidomycin, a specific inhibitor of the non-mevalonate pathway, just like to fosfomycin. E. coli glpT mutants were resistant to fosfomycin and also to fosmidomycin. This fact shows that fosmidomycin was transported inside via the glycerol-3-phosphate transporter, GlpT. DNA micro-array analysis showed that the transcription of glpT and other genes concerning glycerol utilization were highly dependent on the presence of cAMP.

MeSH terms

  • Adenylyl Cyclases / deficiency
  • Adenylyl Cyclases / genetics*
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Cyclic AMP / pharmacology
  • Drug Resistance, Microbial / genetics
  • Escherichia coli / drug effects*
  • Escherichia coli / enzymology
  • Escherichia coli / genetics*
  • Fosfomycin / analogs & derivatives*
  • Fosfomycin / chemistry
  • Fosfomycin / metabolism
  • Fosfomycin / pharmacology*
  • Gene Expression Profiling
  • Genotype
  • Microbial Sensitivity Tests
  • Mutation
  • Oligonucleotide Array Sequence Analysis

Substances

  • Anti-Bacterial Agents
  • Fosfomycin
  • fosmidomycin
  • Cyclic AMP
  • Adenylyl Cyclases